Efficacy and safety of combination of irinotecan and capecitabine in patients with metastatic colorectal cancer after failure of chemotherapy with oxaliplatin

Acta Academiae Medicinae Sinicae

Volumn 31, Issue 3, 2009, Pages 358-361

  Zhou, Jian Feng ^a   Bai, Chun Mei ^a   Cheng, Yue Juan ^a   Jia, Ning ^a   Shao, Ya Juan ^a   Chen, Shu Chang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Efficacy; Irinotecan; Metastatic colorectal cancer; Oxaplatin; Safety; Xeloda

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; HUMAN; LEUKOPENIA; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; TREATMENT OUTCOME;

EID: 67749120730     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2009.03.026     Document Type: Article

References (14)

1. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer [J]. N Engl J Med, 2000, 343(13):905-914. (Pubitemid 30727802)
2. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial [J]. Lancet, 2000, 355(9209): 1041-1047. (Pubitemid 30162806)
3. De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J]. J Clin Oncol, 2000, 18 (16):2938-2947. (Pubitemid 30644117)
4. Grothey A, Sargent D, Goldberg RM, et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment [J]. J Clin Oncol, 2004, 22(7):1209-1214. (Pubitemid 41079833)
5. Tournigand C, Andre T, Achille E, et al. FOLFIRI Mowed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study [J]. J Clin Oncol, 2004, 22(2):229-237. (Pubitemid 41095086)
6. Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [J]. Lancet, 1998, 352(9138):1413-1418. (Pubitemid 28510874)
7. Miwa M, Ura M, Nishida M, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue [J]. Eur J Cancer, 1998, 34(8):1274-1281. (Pubitemid 28342121)
8. Borner MM, Bernhard J, Dietrich D, et al. A randomised phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity [J]. Ann Oncol, 2005, 16(2):282-288. (Pubitemid 40309311)
9. Rea DW, Nortier JW, Ten Bokkel Huinink WW, et al. A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer [J]. Ann Oncol, 2005, 16(7): 1123-1132. (Pubitemid 41418315)
10. Kim TW, Kang WK, Chang HM, et al. Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial [J]. Acta Oncol, 2005, 44(3): 230-235. (Pubitemid 40904125)
11. Park SH, Band SM, Cho EK, et al. First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer [J]. Oncology, 2004, 66(5):353-357. (Pubitemid 39194356)
12. Patt YZ, Lee FC, Liebmann JE, et al. Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results [J]. Am J Clin Oncol, 2007, 30(4):350-357.
13. Hofheinz RD, Gnad-Vogt U, Wein A, et al. Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study [J]. Anticancer Drugs, 2005, 16(1):39-45.